Flanagan W. Michael
SEC Form 4 insider trading activity
Flanagan W. Michael has filed 6 SEC Form 4 filings (9 transaction rows) across 2 companies, including RNA, RNAM, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 22, 2026.
On the most recent filing, Flanagan W. Michael is listed as Chief Scientific Officer at Avidity Biosciences, Inc. Inside the rolling window, Flanagan W. Michael reported no open-market purchases and 2 open-market sales totaling $645K in RNA. The largest disclosed transaction in the window is a sale of 6,534 RNA shares on Jan 21, 2026, worth $473K.
Companies traded
Other insiders at RNA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$645K
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 11, 2025 | RNA | Sale | $779K |
Frequently asked questions
How many SEC Form 4 filings has Flanagan W. Michael made?
Flanagan W. Michael has filed 6 SEC Form 4 filings (9 transaction rows) across 2 companies, including RNA, RNAM since 2025.
Which companies does Flanagan W. Michael trade?
Flanagan W. Michael has filed SEC Form 4 disclosures for 2 companies, including RNA, RNAM.
When was Flanagan W. Michael's most recent SEC Form 4 filing?
Flanagan W. Michael's most recent SEC Form 4 filing on Tracefour is dated Sep 22, 2026.
What is Flanagan W. Michael's total buy and sell value in the current window?
Inside the rolling retention window, Flanagan W. Michael bought $0 and sold $645K based on SEC Form 4 filings.
What was Flanagan W. Michael's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,534 RNA shares on 2026-01-21, worth $473K, per SEC Form 4 filings.